NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES
TORONTO, Sept. 26, 2018 — Canada House Wellness Group Inc. (“Canada House – CSE: CHV”), one of Canada’s leading
vertically integrated providers of medical cannabis products and services, announced today the hiring of Marigold Marketing &
PR (“Marigold”), a top Cannabis PR firm and known specialists in initiating and developing medical and recreational cannabis
Marigold’s hiring comes at a time when Canada House has undergone significant change and success in creating a unique
medically oriented integrated cannabis firm with a strong board and leadership team.
Marigold is recognized as a leader and innovator in the cannabis marketing space, specializing in the development and
execution of integrated marketing and PR campaigns, product development, and social media management for a number of
medical and recreational cannabis brands across North America.
“We believe Canada House has a tremendous value proposition that has not been effectively communicated to the market in
the past. We owe it to our shareholders and to the Corporation to make sure our story is told properly and transparently.
Hiring Marigold accomplishes just this. We look forward to working alongside Bridget Hoffer, Katie Pringle and their team and
growing Canada House into a global industry leader” said Chris Churchill-Smith, CEO, Canada House Wellness Group Inc.
Marigold will be working with CHV’s senior leadership team to further develop the Canada House brand in the medical
cannabis market as well as supporting Canada House’s growth going forward.
“We are delighted to be working with the team at Canada House Wellness Group Inc. They put their patients first and are
setting the global standard for clinical cannabis. We believe CHV is poised to make significant impacts in the Canadian
medical cannabis market” said Bridget Hoffer, Co-Founder, Marigold Marketing & PR.
About Canada House Wellness Group Inc.
Canada House is an experienced, integrated medical cannabis company providing patient-specific cannabinoid therapy
products and services through its clinics and licensed producer. Canada House is the parent company of Marijuana for Trauma
Inc., Knalysis Technologies and Abba Medix Corp. For more information please visit https://www.canadahouse.ca or
About Marigold Marketing & PR
Marigold Marketing & PR is an industry-leading firm that specializes in driving awareness for licensed producers and national
brands. Marigold has launched a division specifically focused for cannabis clients called, Cannabis Communications.
Cannabis Communications focuses on serving the legal medical and recreational markets. For more information please visit
http://marigoldpr.com/ or https://cannabiscoms.com/
For further information, please contact:
Boom Capital Markets
Canada House Wellness Group Inc.
Chris Churchill-Smith, CEO
Cautionary Statement Regarding Forward Looking Information. This press release contains forward-looking statements,
including statements that relate to, among other things, the Company’s clinic, production and technology businesses, its
future plans, the Company’s markets, objectives, goals, strategies, intentions, beliefs, expectations and estimates, and can
generally be identified by the use of words such as “may”, “will”, “could”, “should”, “would”, “likely”, “possible”, “expect”,
“intend”, “estimate”, “anticipate”, “believe”, “plan”, “objective” and “continue” (or the negative thereof) and words and
expressions of similar import. Although the Company believes that the expectations reflected in such forward-looking
statements are reasonable, such statements involve risks and uncertainties, and undue reliance should not be placed on
such statements. Certain material factors or assumptions are applied in making forward-looking statements, and actual
results may differ materially from those expressed or implied in such statements. Material assumptions used to develop
forward-looking information in this news release include, among other things, the regulations related to cannabis use under the
Access to Cannabis for Medical Purposes Regulations and the act respecting cannabis and to amend the Controlled Drugs
and Substances Act, the Criminal Code and other Acts, passed by the Canadian Federal government, making cannabis legal
for recreational use by October 17, 2018; Company liquidity and capital resources, including the availability of additional
capital resources to fund its activities; level of competition; the ability to adapt products and services to the changing market;
the ability to attract and retain key executives; and the ability to execute strategic plans. Additional information about material
factors that could cause actual results to differ materially from expectations and about material factors or assumptions
applied in making forward-looking statements may be found in the Company’s most recent annual and interim Management’s
Discussion and Analysis under “Risk and Uncertainties” as well as in other public disclosure documents filed with Canadian
securities regulatory authorities. The Company does not undertake any obligation to update publicly or to revise any of the
forward-looking statements contained in this document, whether as a result of new information, future events or otherwise,
except as required by law.”
Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility
for the adequacy or accuracy of this release.